Impact of erythropoietin therapy on cardiorenal syndrome: A systematic review with meta-analysis

doi:10.4330/wjc.v15.i5.273

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3361)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-1) series.

Item

Count

PDF

136

WORD

HTML

1809

Figures (1-3)

143

Tables (1-1)

151

Sum=2276

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

150

Download

412

Sum=562

Publishing Process of This Article

Item

Count

Browse

133

Download

390

Sum=523

May 26, 2023 (publication date) through Jul 17, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Cardiology

ISSN

1949-8462

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Cardiol. May 26, 2023; 15(5): 273-283
Published online May 26, 2023. doi: 10.4330/wjc.v15.i5.273

Full Size Figure Download Figure

Figure 3 Funnel plot of all causes of hospitalization of erythropoietin vs non-erythropoietin.

Citation: Bhangal R, Cancarevic I, Nassar M, Umar Z. Impact of erythropoietin therapy on cardiorenal syndrome: A systematic review with meta-analysis. World J Cardiol 2023; 15(5): 273-283
URL: https://www.wjgnet.com/1949-8462/full/v15/i5/273.htm
DOI: https://dx.doi.org/10.4330/wjc.v15.i5.273